02 October 2023 | Monday | News
“This partnership with Cardiac Imaging allows unprecedented access of RUBY Rubidium Elution System™ and RUBY-FILL® (Rubidium Rb82 generator) to various types of facilities interested in performing cardiac PET,” said Sergio Calvo, President, Jubilant Radiopharma, Radiopharmaceuticals Division. “Given our mutual goal to expand patient access to state-of-the-art myocardial perfusion, the partnership was a natural next step for both companies. Cardiology practices will have the ability to start a cardiac PET program on a part-time basis, and then determine how it will fit into a broader program for their patients in the future.”
“At Cardiac Imaging, our priority has always been to provide patients with access to the leading cardiac care services. Through our partnership with Jubilant, we’re able to further that mission and offer a Cardiac PET solution for every practice,” said Sam Kancherlapalli, CEO, Cardiac Imaging, Inc. “Our daily-leased rubidium program is the newest addition to our portfolio, and we’re thrilled to have an innovative, patient-centric partner in Jubilant as we continue to drive forward.”
Cardiac Imaging, Inc. is the nation’s leading provider of cardiac PET services through their mobile and fixed site services. Their cutting-edge fleet of mobile coaches delivers all-inclusive Cardiac PET/CT imaging services straight to cardiologists’ offices. Cardiac Imaging, Inc.’s fixed site program is a comprehensive turnkey offering, enabling physicians to administer Cardiac PET in their own facilities. Through these solutions, Cardiac Imaging, Inc. is advancing the field of cardiac PET and delivering premier cardiac care across the US.
© 2023 Biopharma Boardroom. All Rights Reserved.